Biorithm, a Singapore-based women’s health MedTech, has closed $3.5 million in Series A funding, co-led by Adaptive Capital Partners and SEEDS Capital, investment arm of government agency Enterprise Singapore. The funding will be utilized to double down on expanding the reach of the firm’s connected pregnancy management solutions firstly across Southeast Asia and the United States.